These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 14655446)

  • 1. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric outpatients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145(42):55. PubMed ID: 14655446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptics for behavioral symptoms of dementia.
    Reynolds PL; Strayer SM
    J Fam Pract; 2000 Jan; 49(1):78-9. PubMed ID: 10678345
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
    Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone questioned as dementia first-line treatment.
    Saxe T
    Geriatrics; 2004 Feb; 59(2):11; author reply 11-2. PubMed ID: 14989589
    [No Abstract]   [Full Text] [Related]  

  • 8. Risperidone treatment of an adolescent with severe posttraumatic stress disorder.
    Keeshin BR; Strawn JR
    Ann Pharmacother; 2009 Jul; 43(7):1374. PubMed ID: 19584378
    [No Abstract]   [Full Text] [Related]  

  • 9. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
    MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
    Grossman F; Okamoto A; Turkoz I; Gharabawi G
    J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficasy and safety of the use of risperidone (rispoluxe) in demented patients with psychotic and behavioural disorders].
    Bocharov AV; Kondakova VE; Tuleninov ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):25-31. PubMed ID: 22983233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Chan et al. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 16: 1156 - 1162.
    Onalaja D; Jainer AK
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1076-7; author reply 1077. PubMed ID: 12404659
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the behavioral manifestations of dementia.
    Yeager BF; Farnett LE; Ruzicka SA
    Arch Intern Med; 1995 Feb; 155(3):250-60. PubMed ID: 7832596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
    Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of a pregnancy with risperidone microspheres.
    Dabbert D; Heinze M
    Pharmacopsychiatry; 2006 Nov; 39(6):235. PubMed ID: 17124649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.